First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial
Articles > Article · 2025
Authors: Martin H. Voss, Howard Gurney, Vagif Atduev, Cristina Suarez, Miguel A. Climent, David Pook, Piotr Tomczak, Philippe Barthélémy, Jae Lyun Lee, Taron Nalbandian, Viktor Stus, Thomas Ferguson, Pawel Wiechno, Erhan GÖKMEN, Louis Lacombe, Craig Gedye, Jerry Cornell, Manish Sharma, Joseph E. Burgents, Laurence Albiges
European Urology, International, WoS, 2025, vol 88, pp 614-624